Andrew Emmett on PDUFA and the 2012 BIO International Convention

Type:

Video

Andrew Emmett, Managing Director, Science & Regulatory Affairs, speaks about the important regulatory issues facing the industry, specifically PDUFA reauthorization, the FDA and regulation. Also, hear his programming highlights from the Achieving Regulatory Approval and Compliance Track at the upcoming 2012 BIO International Convention.

December 8, 2010 Intellectual Property in Emerging Markets	July 29, 2010 DOE’s Assistant Secretary Zoi Announces Funding of $24 million Research Groups	June 23, 2010 BioBytes: The Biotech Drug Delivery Timeline	June 15, 2010 BioBytes: Biotechnology and Diagnostic Tools
June 1, 2010 BioBytes: Marine Biotechnology	May 25, 2010 BioBytes: Biotechnology and Plant Made Pharmaceuticals	May 19, 2010 BioBytes: Forensics and Biotechnology	May 19, 2010 BioBytes: Forensics and Biotechnology